Ciprofloxacin Zentiva 250 mg

Ciprofloxacin Zentiva 250 mg is a medicine authorised by Swissmedic under authorisation number 56650. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 March 2004 and the authorisation is valid without a time limit. ATC code J01MA02 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 56650
  • ATC J01MA02
  • Synthetic medicines
Authorisation data
Authorisation number56650
NameCiprofloxacin Zentiva 250 mg
Full nameCiprofloxacin Zentiva 250 mg, Filmtabletten
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01MA02
First authorisation09 March 2004
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ciprofloxacin Zentiva 250 mg, FilmtablettenA09 March 2004
2Ciprofloxacin Zentiva 500 mg, FilmtablettenA09 March 2004
3Ciprofloxacin Zentiva 750 mg, FilmtablettenA09 March 2004

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
210Tablette(n)J01MA0208.01.8.A
420Tablette(n)J01MA0208.01.8.A
610Tablette(n)J01MA0208.01.8.A
820Tablette(n)J01MA0208.01.8.A
1020Tablette(n)J01MA0208.01.8.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ciprofloxacin Zentiva 250 mg authorised in Switzerland?

Yes. Ciprofloxacin Zentiva 250 mg is authorised by Swissmedic under authorisation number 56650, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ciprofloxacin Zentiva 250 mg have?

Ciprofloxacin Zentiva 250 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Ciprofloxacin Zentiva 250 mg?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com